TITLE:
Amiodarone-induced bronchiolitis obliterans organizing pneumonia in patient following percutaneous transluminal coronary angioplasty
AUTHORS:
Massimo Bolognesi, Diletta Bolognesi
KEYWORDS:
Percutaneous Transluminal Coronary Angioplasty; Amiodarone; BOOP
JOURNAL NAME:
Case Reports in Clinical Medicine,
Vol.2 No.9,
December
13,
2013
ABSTRACT: Background: Many
patients are affected by idiopathicbronchiolitis obliterans organizing pneumonia
(BOOP). There are several known causes of BOOP, and several systemic disorders
have BOOP as an associated primary pulmonary lesion. Numerous agents including
cytotoxic and noncytotoxic drugs have the potential to cause pulmonary
toxicity. Descriptions of amiodarone-related BOOP continue to be reported
throughout the world. Case Report: We reported a patient with original clinical
presentation who developed recurrent sustained ventricular tachycardia (SVT)
despite the presence of implantable
cardioverter-defibrillator (ICD), hypoxaemia and interstitial
pneumonitis in both lung bases. After percutaneous
transluminal coronary angioplasty, he developed bronchiolitis obliterans
organizing pneumonia (BOOP). Conclusions: To our knowledge, such complications
after percutaneous coronary procedure in patients with amiodarone therapy for
arrhythmia prophylaxis, are not very frequent in literature.